SOX2 and non-small cell lung carcinoma: SOX2 amplification and overexpression is more common in squamous cell carcinomas (SCC) than in lung adenocarcinomas (ADC) [4] and the prognostic impact of SOX2 overexpression in NSCLC appears to be dependent on the histologic subtype [17], [18].